# OnCo record molecular-partners (company). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix owl: <http://www.w3.org/2002/07/owl#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/companies/molecular-partners/>
  a schema:Organization ;
  onco:kind "company" ;
  schema:identifier "molecular-partners" ;
  schema:name "Molecular Partners"@en ;
  schema:alternateName "Molecular Partners AG"@en ;
  schema:description "Molecular Partners is a Switzerland-based radiopharmaceutical company running 2 late-stage cancer trials of [212Pb]Pb-MP0712 and MP0533 with Obinutuzumab pretreatment in neuroendocrine tumours, non-small-cell lung cancer and pancreatic ductal adenocarcinoma."@en ;
  schema:url <https://onco.cc/companies/molecular-partners/>, <https://www.molecularpartners.com> ;
  schema:dateModified "2026-09-11"^^xsd:date ;
  schema:sameAs <https://en.wikipedia.org/wiki/Molecular_Partners> ;
  owl:sameAs <http://www.wikidata.org/entity/Q25111777> ;
  schema:citation <https://www.molecularpartners.com>, <https://clinicaltrials.gov/search?lead=Molecular%20Partners%20AG>, <https://www.molecularpartners.com/pipeline> ;
  onco:tag "ctgov-sponsor" ;
  schema:addressCountry "CH" ;
  onco:cancers <https://onco.cc/cancers/neuroendocrine/>, <https://onco.cc/cancers/nsclc/>, <https://onco.cc/cancers/pancreatic/>, <https://onco.cc/cancers/urothelial/>, <https://onco.cc/cancers/aml/> ;
  onco:trials <https://onco.cc/trials/nct04115306/>, <https://onco.cc/trials/nct05673057/>, <https://onco.cc/trials/nct07278479/> .